Investing in Breakthrough Therapies For The Brain

Specialist life sciences venture capital firm

Parkinson’s Pioneer Capital Advisors Ltd has been set up as a life sciences venture capital firm focussed on early-stage investments in life-changing treatments for people with Parkinson’s disease and related neurological conditions

The firm leverages its extensive networks and relationships with co-investors across the biotech ecosystem

The time is now - recent genetic and cell biology advances in Parkinson’s pathophysiology present exciting opportunities for novel treatments, and advances in clinical trials are smoothing the runway

The firm’s vision is underpinned by a shared belief in the transformational potential of

• Scientific innovation and new drug development technologies

• Patient impact and commercial success